David Williams, MD

Trials

Studies that name David Williams, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:34 UTC. Open this list on ClinicalTrials.gov

• Ph3
  NCT05600426 · A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202)

  Boston Children's Hospital · terminated · Severe Aplastic Anemia · principal investigator
• Ph3
  NCT02016482 · A Study to Evaluate the Safety and Efficacy of Adalimumab in Subjects With Chronic Plaque Psoriasis and Nail Psoriasis

  AbbVie · completed · Nail Psoriasis, Plaque Psoriasis · study director
• Ph2/Ph3
  NCT01896102 · A Study of the Efficacy and Safety of Hematopoietic Stem Cells Transduced With Lenti-D Lentiviral Vector for the Treatment of Cerebral Adrenoleukodystrophy (CALD)

  Genetix Biotherapeutics Inc. · completed · Cerebral Adrenoleukodystrophy (CALD) · principal investigator
• Ph3
  NCT01468207 · Efficacy and Safety Study of Adalimumab in Treatment of Hidradenitis Suppurativa

  AbbVie (prior sponsor, Abbott) · completed · Hidradenitis Suppurativa (HS) · study chair
• Ph2/Ph3
  NCT00604799 · VALOR: The Talent Thoracic Stent Graft System Clinical Study

  Medtronic Cardiovascular · completed · Thoracic Aortic Aneurysms · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 00:34 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
  UG3HL157564 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI Michael A Pulsipher, DAVID A WILLIAMS · fiscal years 2022
  Named on NCT05600426
• 1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
  U24HL157560 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI Bronwen Shaw · fiscal years 2022 to 2025
  Named on NCT05600426